BOB体育

Skip to main content

Desmond A Schatz, MD : Research

Pediatric Endocrinologist (Child Hormone Specialist)

Photo of Desmond A Schatz

Research at a glance

Top areas of exploration

  • Diabetes Mellitus, Type 1 , 253 publications
  • Autoantibodies , 92 publications
  • Insulin , 68 publications
  • Islets of Langerhans , 49 publications

Research activity

381 publications

23,284 citations

Why is this important?

Active clinical trials

ITN095AI DESIGNATE

This is a multicenter, Phase Ib, open-label, siplizumab dose-finding study in individuals aged 8-45 years with a Type 1 diabetes mellitus (T1DM) diagnosis. within 18 months of V0. Participants will be randomized 1:1:1:1 to one of four possible鈥�

Investigator
Desmond A Schatz
Status
Accepting Candidates
Ages
8 Years - 45 Years
Sexes
All

My publications

381 publications

2022

Cost-Effectiveness of Low-Dose Antithymocyte Globulin Versus Other Immunotherapies for Treatment of New-Onset Type 1 Diabetes.

Diabetes technology & therapeutics

鈥�

2022

Improving the Prediction of Type 1 Diabetes Across Ancestries.

Diabetes care

鈥�

2022

Incidence Trends of New-Onset Diabetes in Children and Adolescents Before and During the COVID-19 Pandemic: Findings From Florida.

Diabetes

鈥�

2022

Index60 Is Superior to HbA1c for Identifying Individuals at High Risk for Type 1 Diabetes.

The Journal of clinical endocrinology and metabolism

鈥�

2022

Rising Hemoglobin A1c in the Nondiabetic Range Predicts Progression of Type 1 Diabetes As Well As Oral Glucose Tolerance Tests.

Diabetes care

鈥�